Average Co-Inventor Count = 7.82
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Abbvie Inc. (16 from 822 patents)
2. Abbott Laboratories Corporation (5 from 4,177 patents)
21 patents:
1. 11964990 - 1,3,4,7-tetrahydro-2H-pyrrolo[3′,2′:5,6]pyrido[2,3-b][1,4]oxazepine bcl-2 inhibitors
2. 11786519 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
3. 10676485 - Macrocyclic MCL-1 inhibitors and methods of use
4. 10640563 - Anti-B7-H3 antibodies and antibody drug conjugates
5. 10081628 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
6. 9877958 - Apoptosis-induced agents for the treatment of cancer and immune and autoimmune diseases
7. 9844547 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
8. 9266877 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
9. 9227963 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
10. 9051327 - Pyridazino[4,5-D]pyrimidin-5(6H)-one inhibitors of kinases
11. 8940737 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
12. 8901152 - Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme
13. 8889675 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
14. 8883784 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
15. 8796289 - Pyridazino[4,5-D]pyrimidin-5(6H)-one inhibitors of kinases